Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.47%)
As of: Nov 16, 2026 · 1:38 PM EST

Elite Pharmaceuticals (ELTP) Short term Debt (2009 - 2026)

Updated

Elite Pharmaceuticals' Short term Debt came in at $240,170 for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 3.8% from $231,351 a year earlier and up 4.5% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Short term Debt (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Short term Debt was $228,596, down 7.3% from FY2025.

  • Short term Debt has declined in each of the last six fiscal years, with a five-year compound annual growth rate of -11.1% (FY2021 to FY2026).
  • Going back by fiscal year, Short term Debt was $246,566 in FY2025 (-16.8%), $296,221 in FY2024 (-4.7%), $310,854 in FY2023 (-12.1%) and $353,828 in FY2022 (-13.9%).
  • The fiscal Q2 2027 figure represents the highest quarterly Short term Debt since fiscal Q4 2025.
  • Year-over-year, Short term Debt increased in 1 of the last eight quarters, with an average decline of 16.4%.
  • The fastest year-over-year change in Short term Debt over five years came in fiscal Q1 2024 (growth of 118.5%), and the weakest in fiscal Q1 2023 (a decline of 80.3%).
  • Business Quant data shows ELTP's Short term Debt at $229,726 (Q1 2027), $228,596 (Q4 2026) and $227,502 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,287.23 Bn 1,260.84 Bn 20.46 Bn
2 Johnson & Johnson 685.24 Bn 605.10 Bn 17.30 Bn
3 AbbVie 523.42 Bn 491.43 Bn 13.12 Bn
4 Merck 361.12 Bn 324.06 Bn 13.19 Bn
5 Novartis Ag 312.86 Bn 286.10 Bn -
6 Astrazeneca 286.52 Bn 260.04 Bn 13.26 Bn
7 Amgen 252.28 Bn 203.93 Bn 7.58 Bn
8 Gilead Sciences 209.33 Bn 184.44 Bn 6.73 Bn
9 Pfizer 165.02 Bn 112.37 Bn 12.56 Bn
10 Elite Pharmaceuticals 393.15 Mn 266.57 Mn 15.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 240,170.00
Jun 30, 2026 229,726.00
Mar 31, 2026 228,596.00
Dec 31, 2025 227,502.00
Sep 30, 2025 231,351.00
Jun 30, 2025 230,621.00
Mar 31, 2025 246,566.00
Dec 31, 2024 289,999.00
Sep 30, 2024 367,880.00
Jun 30, 2024 429,608.00
Mar 31, 2024 296,221.00
Dec 31, 2023 306,429.00
Sep 30, 2023 295,147.00
Jun 30, 2023 251,276.00
Mar 31, 2023 310,854.00
Dec 31, 2022 471,438.00
Sep 30, 2022 502,601.00
Jun 30, 2022 115,000.00
Mar 31, 2022 353,828.00
Dec 31, 2021 400,423.00
API Access

Elite Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY